In defense of Lance Armstrong

lanceFrom the European Society of Cardiology (ESC) 2013 Congress

In evaluating the overall mortality rates of French cyclists who rode in the prestigious event between 1947 and 2012, investigators found the cyclists had a 41% lower mortality rate than men in France and that this lower mortality rate was consistent over time, including periods of reported heavy performance-enhancing-drug use.

There you have it! Lance, after surviving testicular cancer, was just trying to increase his chances of a longer life.

In light of that, maybe we could all benefit from a few performance enhancing drugs, and far less war on their use.